Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.
Kaur
Nirmal
N
State University of New York at Buffalo, Department of Medicine, VA Upstate New York, 3495 Bailey Avenue, Buffalo, New York 14215, USA.
Mahl
Thomas C
TC
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000935:Antifungal Agents; D000069285:Infliximab